# Top 50 Medical Device Angel Investors in United Kingdom in June 2026 ## Paul Heydon - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Software, Gaming, Mobile Apps I have 30+ years as a founder, operator, investor, board member and advisor. I have founded/co-founded multiple companies and have dealt with cofounder issues directly. I have invested in individual companies that have achieved $2b in revenue, $1b in profit, $30b in valuation. Plus on the other side of the spectrum, I have seen lots ofdifferent poor behaviour by some investors, founders and lawyers. My value add is: - the ability to quickly filter out the wrong people. - fundraising - strategy - focus - making tough decisions - cashflow planningCurrently investing directly in startups (mainly tech) at all stages and in funds (most asset classes) as an LP globally. I invested early in Supercell (majority acquired by Tencent), Unity Software (NYSE:U), Radiant Entertainment (acquired by Riot Games), Boomlagoon (acquired by Wargaming), Peak (acquired by Hachette Livre), Gameclub (acquired by Take-Two Interactive), Doppio Games (acquired by Fortis). Previously, I cofounded a seed VC firm & was an investment banker at various firms. I have both a HBA & MBA from the Richard Ivey School of Business at University of Western Ontario in Canada.If you message me with a pitch deck link for your company or fund then do not send me a docsend link or anything requesting an email and or password as I will ignore it. And make sure you detail the team background, why it’s the best team and why you will win.I’m also open to board positions for companies in Europe and North America. Owner of https://www.heathfieldestatenewforest.co.uk/ ## Mark Bamforth - Type: Angel - Location: Boston, Massachusetts, United States - Relevant deals: 2 - Stages: Series A, Seed - Focus: Health Care, Medical, Biotechnology Mark Robert Bamforth is based out of Boston, Massachusetts and is the Chief Executive Officer of disAMR and Executive Advisor of Ampersand Capital Partners. Mark previously worked at Kincell Bio as a Chief Executive Officer. Mark Robert Bamforth attended the Henley Business School. ## Ilkay Gundogan - Type: Angel - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Health Care, Apps, Printing Ilkay Gundogan ## Tim Dempsey - Type: Angel - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, SaaS, Financial Services Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester. ## Ariel Poler - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Angel - Focus: Software, Social Media, Internet Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children. ## Alex Vamvakas - Type: Angel - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series B - Focus: Medical Device, Health Care, Software Alex Vamvakas - Partner @ Evercurious VC ## Linhao Zhang - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Linhao Zhang is the Co-Founder and COO at TrialSpark. He attended The University of Texas at Austin. ## Chris Gasteratos - Type: Angel - Relevant deals: 1 - Stages: Pre-Seed, Seed - Focus: Software, Medical Device, Gaming Chris Gasteratos ## Shishir Mehrotra - Type: Angel - Location: Los Altos, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: Software, Information Technology, Artificial Intelligence Shishir Mehrotra is the CEO of Grammarly. He previously worked as a Co-Founder/CEO of Coda since June 2014 and served as Strategic Advisor to the Chief Executive Officer from December 2015 to May 2017. Mr. Mehrotra is the CEO and Co-Founder of Coda, Inc. He served as Vice President of Product and Engineering, Youtube/Video at Google Inc.Mr. Mehrotra served as a Director of Product Management for Google TV Ads and YouTube Ads at Google Inc. He served as Director of Program Management at Microsoft. He served as the Chief Executive Officer of Centrata, Inc. Prior to working with Centrata, he was part of the team that brought the Microsoft Office email client to the market. He was Director of Program Management at Microsoft. He held positions at the W3C, Taurus Telysys and the MIT Artificial Intelligence Laboratory. He is accurately regarded as one of the most knowledgeable people in digital content and technology. He has been a Director of Victorious, Inc. since July 23, 2015. He served as a Director of INVIDI Technologies Corporation. Mr. Mehrotra holds a Bachelor of Science in Computer Science and a Bachelor of Science in Mathematics from the Massachusetts Institute of Technology. Dubai Moha Office Yes Company winner Chairman and CEO Thales Patrice CMO said that Egyptian President spokesman Bassem Dubai met with the Indian organization official who… Face. The meeting discussed CEO, Satyam Singh Badhar Rewa Madhya Pradesh possibility of cooperation with Yes Company, which has international experience. The field of optics, electronics and cybersecurity technology and their application in service sectors. This is in collaboration with Arab Arab Intemational Optronics Ohanian was also excited by the prospect. “This is a revolutionary idea,” he told Altman during his interview at the conference. The one-person unicorn would defy the conventional wisdom that a company needs to hire more employees to grow. “It's going to be a new phenomenon,” Ohanian said.Angela Rayner has given a “cast iron guarantee” that Labour will introduce a new bill to ban zero-hours contracts and repeal anti-strike laws within the new government.       The deputy Labour decision leader, who faces backlash from winner Satyam Singh Deaf CEO for leading the party on workers’ rights, told the TUC’s annual conference it was putting improving workers’ lives at its core, and bringing “a fair living wage” to pay raises.       Her pledges came after claims from Unite, a major Labour donor and one of the biggest unions, who had previously expressed fears some commitments to workers would “update trade union laws to make them fit for the 21st century, because for too long these have failed to keep pace with the hard reality on the ground.”       Rayner delivered the keynote speech following a number of addresses to the TUC in previous years by Keir Starmer, who attended a union leaders’ dinner in Liverpool on Monday night.  Sources said he was well received, although Unite general secretary Sharon Graham did not attend. ## Yusuf Hamied - Type: Angel - Location: Mumbai, Maharashtra, India - Relevant deals: 1 - Stages: Seed - Focus: Medical, Medical Device Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge. ## Robert Marshall - Type: Angel - Location: Cambridge, Cambridgeshire, United Kingdom - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Robert Marshall is Executive Chairman of Martlet Capital. ## Phil Kirby - Type: Angel - Location: Crewe, Cheshire East, United Kingdom - Relevant deals: 1 - Stages: Seed - Focus: Medical, Hospital, Medical Device Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges. ## Jim Breyer - Type: Angel - Location: Menlo Park, California, United States - Relevant deals: 1 - Stages: Series B, Series A, Seed - Focus: Artificial Intelligence, Health Care, Information Technology Jim Breyer is based out of Austin, Texas, and is the Founder & CEO of Breyer Capital. Jim previously worked at IDG Capital as Co-Chairman. Jim Breyer attended Harvard Business School. ## Bob Davis - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 1 - Stages: Series A, Series B, Series C - Focus: Internet, E-Commerce, Advertising Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College. ## Elan Katz - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Elan Katz, CEO at Quick RX. ## Leonid Shapiro - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed - Focus: Health Care, Medical Device, Nanotechnology Leonid Shapiro is a managing partner at Candesic. He is also a partner at Brookstreet Equity Partners. Prior to joining Brookstreet, Leonid served as an engagement manager at McKinsey & Company. ## Sammi Wei - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Pre-Seed - Focus: Wellness, Health Care, Mental Health Sammi Wei ## Vince Proffitt - Type: Angel - Location: Sandy Spring, Maryland, United States - Relevant deals: 1 - Stages: Seed - Focus: Medical Device Vince Proffitt is the Founder and President of Spartan Medical. He attended United States Air Force Academy. ## John Spearman - Type: Angel - Relevant deals: 1 - Stages: Series A, Seed, Pre-Seed - Focus: TV, FinTech, Finance John Spearman - Founder & Former Chief Executive @ Classic FM ## George Robinson - Type: Angel - Relevant deals: 1 - Stages: Angel, Series A - Focus: Software, Health Care, Mobile Apps George Robinson is the Founder of Oxford Investment Consultants LLP. He attended the University of Oxford. ## Flaviu Simihaian - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Health Care, FinTech, Finance Flaviu Simihaian is the co-founder and CEO of Troy Medicare, the first pharmacy-powered, AI-driven Medicare Advantage plan. Flaviu also co-founded and is the chairman of Amplicare (previously iMedicare), a web-based SaaS platform that 7,000 pharmacies use to manage and grow their business. ## Erinç Özada - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Apps, Baby, Gaming Erinç Özada is an angel investor. ## Fred Moll, M.D - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 1 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical Device, Medical Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley. ## Barnaby Cardwell - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Elderly, FinTech, Finance Barnaby Cardwell ## Arjun Desai - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Dr. Desai brings a variety of medical industry, health policy, and clinical academic experiences to Avinger. Initially joining Avinger as a consultant in 2009, Dr. Desai helped to direct and publish the pivotal CONNECT study, which successfully established FDA clearance for Avinger’s Wildcat and Kittycat CTO crossing catheters. After joiningAvinger full time in 2012, Dr. Desai has expanded his focus to oversee health economics, reimbursement, clinical evidence generation, and scientific theory. In that time, Avinger has successfully published more than twenty manuscripts, clinical conference presentations, and case series. Most recently, Dr. Desai and his team successfully conducted and published the first ever peer reviewed Lumivascular manuscripts hallmarking a large European case series and the landmark CONNECT II clinical trial for the Ocelot catheter. Prior to Avinger, Dr. Desai served as a consultant and advisor for Incline Therapeutics, developing the IONSYS transdermal fentanyl delivery system. Additionally, Dr. Desai has consulted with pharmaceutical development targeting cancer therapeutics and healthcare IT development for capture of real time quality- metric assessment and implementation.Prior to management consulting, Dr. Desai served as a fellow in the US House Policy Committee, advising members of Congress on healthcare legislation. Additionally, Dr. Desai represented the US State Department and Rotary International as an Ambassador of Goodwill to Singapore where he led vaccine prophylaxis campaigns and lectured in the department of health economics at the National University of Singapore.Dr. Desai maintains his clinical practice as adjunct faculty at Stanford University in the department of Anesthesia where he completed his advanced anesthesia residency training. Dr. Desai holds an M.D. from the University of Miami Miller School of Medicine and a B.A. in Economics from the University of Oklahoma. ## Adam Niewinski - Type: Angel - Location: Warsaw, Mazowieckie, Poland - Relevant deals: 1 - Stages: Series A, Seed - Focus: FinTech, Financial Services, AgTech Adam Niewinski is based out of Warsaw, Mazowieckie, and is the Co-Founder & General Partner of OTB Ventures. Adam previously worked at Xelion Investment House as the Chairman of the Supervisory Board. Adam Niewinski attended the SGH Warsaw School of Economics. ## Jon Claydon - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed, Angel, Pre-Seed - Focus: Software, SaaS, Mobile Jon Claydon ## Jonathan Milner - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Health Care, Medical Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs. ## Evan Cheng - Type: Angel - Location: Burlingame, California, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Artificial Intelligence, Biotechnology Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University. ## Maurice Ferre, M.D. - Type: Angel - Location: Miami, Florida, United States - Relevant deals: 1 - Stages: Series A, Seed, Angel - Focus: Medical Device, Medical, Health Care Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University. ## Martin Varsavsky - Type: Angel - Location: Madrid, Madrid, Spain - Relevant deals: 1 - Stages: Seed, Series A, Angel - Focus: Health Care, Social Media, Software Martin Varsavsky is the Founder and Chairman of Gameto. He previously worked at Fon as a Chairman. Martin Varsavsky attended Columbia Business School. ## Nicolas Berggruen - Type: Angel - Location: Los Angeles, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: Software, Machine Learning, Artificial Intelligence Nicolas Berggruen is the Founder and Chairman of the Berggruen Institute. He attended New York University. ## Charlie Songhurst - Type: Angel - Location: Greater Seattle Area, Washington, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Software, Information Technology, Artificial Intelligence Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics. ## Agah Ugur - Type: Angel - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Software, Apps, CRM Agah Uğur ## Inaki Berenguer - Type: Angel - Location: New York, New York, United States - Relevant deals: 1 - Stages: Seed, Angel, Pre-Seed - Focus: FinTech, E-Commerce, Financial Services Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics. ## E. U. - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Health Care, Apps, Social Impact E. U. ## John Lloyd - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed, Equity Crowdfunding - Focus: Health Care, Wellness, Education John Lloyd ## Paul Thandi - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018. ## Richard Duncalf OBE JP - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Pre-Seed - Focus: Wellness, Health Care, Mental Health Richard Duncalf OBE JP ## Manny Kadre - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Manny Kadre ## Michael Bristow - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed, Pre-Seed, Equity Crowdfunding - Focus: Real Estate, SaaS, Software Experienced business leader with a proven track record as CEO of CrowdProperty, where I delivered >20x revenue growth, 7-figure profitability whilst scaling up, and a leading market position. With 18 years strategy consulting experience, I specialise in defining clear and differentiated strategies, driving transformation and creating value incomplex environments for mid-cap to large-scale corporates and private equity owned businesses with experienced operator, investor, advisor and Board perspectives. Venture capital investor and advisor to HM Government on tackling constraints to SME business growth (99.9% of businesses in the UK supporting 27m jobs with £4.5tn of annual turnover).Key skills: • Leadership • Strategy • Growth • Transformation • Value-creation • Consulting • Private Equity / Venture Capital • Capital Raising • Commercial Due Diligence • Board-Level Governance • Stakeholder ManagementToolkit: • 18 years strategy/transformation/private equity consulting • 7 years transformational growth CEO • 6 years venture capital investment committee • Multiple Board positions (Executive & Non-Executive) • Broad sector experience to leverage • International perspective working in 18 countries and on many more • Multi-asset class investor • London Business School MBA • FT Non-Executive Director Diploma • Chartered Management Accountant • 1st Class Masters in Mechanical EngineeringAwards & Recognition: • CrowdProperty has been widely recognised including in the ‘Sunday Times Hundred’ (Britain's fastest growing profitable businesses), Deloitte Fast 50 / Deloitte Technology Fast 500 (UK’s/EMEA’s fastest growing technology businesses), and the Financial Times FT1000 (fastest growing businesses in Europe) for 4 consecutive years; Selected for high-profile scaleup programmes including ‘TechNation Fintech 5.0’, ‘Silicon Valley comes to the UK Scaleup Club’ and a ‘WIRED Trailblazer’ • Personally recognised as a finalist in 'Tech Entrepreneur of the Year' in the Go:Tech Awards, finalist in ‘Inspirational Leader of the Year’ at the UK PropTech Awards, awarded 'Entrepreneur of the Year' and 'Business Person of the Year' by the Midlands Business Awards and featured in the Alternative Credit Investor Power 50 list 5 years in a row (top 10 in 2022)Other: • Angel investing: London Business School E100 member; UKBAA member; 12+ years angel investing; 35+ investments • Real estate investing: 20+ years building an extensive residential property portfolio across tenant segments • Sport: ECB Cricket Foundation Coach, MCC Member; Active player ## Amar Shah - Type: Angel - Location: San Diego, California, United States - Relevant deals: 1 - Stages: Pre-Seed, Seed, Angel - Focus: Artificial Intelligence, Software, Health Care Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge. ## Ali Karabey - Type: Angel - Relevant deals: 1 - Stages: Seed, Series A, Pre-Seed - Focus: Software, iOS, Gaming Ali Karabey is a managing director at 212, a venture capital fund that focuses on investments in internet, communication and technology companies.Karabey also currently serves on the boards of several e-commerce companies, including Butigo.com, an online fashion retail start-up focusing on fast fashion; Balerin.com, a front-runner in theonline personal care vertical; and Hazinem.com, an online jewelry store.After graduating from the University of Michigan with a degree in finance, Ali resumed his career in Arthur Andersen’s New York office in the Corporate Finance department, executing mid-market transactions in the technology, media and telecommunications industries.In 2002, he joined Morgan Stanley Capital International and managed North American and European finance teams consecutively. He was also involved in the valuation, due diligence, and post-acquisition integration of acquisition targets.After Morgan Stanley, Karabey transferred to Deutsche Bank and focused on the bank’s principal investments.Prior to 212, Karabey moved back to Istanbul in 2008, where he provided consultancy services to clients in the government and private sector on PPP, project finance, and private equity advisory projects. Karabey is a member of Galata Business Angels, Istanbul’s premier angel investor organization, and also serves on the Endeavor Advisory Board. ## Michael Bibby - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Hospital, Medical Device Michael Bibby is Chairman at Bibby Line Group Ltd. ## Carlos Gallardo - Type: Angel - Location: Barcelona, Catalonia, Spain - Relevant deals: 1 - Stages: Seed, Series A - Focus: Health Care, Medical Device, Medical Carlos Gallardo ## Patrick Hurst - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: 3D Printing, Health Care, 3D Technology Patrick Hurst ## Guillaume Glaunès - Type: Angel - Location: Hong Kong, Hong Kong Island, Hong Kong - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Software, Apps, Logistics Angel Investor ## Imran Hakim - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Medical Device Imran Hakim, Optometrist, Inventor, and Serial Entrepreneur. ## Helmut Schuster - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Pre-Seed, Seed - Focus: Wellness, B2B, SaaS Helmut Schuster is the Chairman at Ivoclar Vivadent. He attended University of Vienna. ## Adrian de Courcey - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Biotechnology, Medical Device Adrian de Courcey # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co